# A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)

Study · id `cardio:ct-nct02414841` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02414841](<https://clinicaltrials.gov/study/NCT02414841>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02414841

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 696 participants.

## Technical summary

Registry record NCT02414841. Randomized; quadruple masking; primary purpose treatment. Start 2015-08 (actual); primary completion 2018-02 (actual). Results posted on 2019-08-13.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 696 participants (enrolled count; ClinicalTrials.gov record NCT02414841, source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)
- Started: 2015-08 (actual) (ClinicalTrials.gov record NCT02414841, source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)
- Primary completion: 2018-02 (actual) (ClinicalTrials.gov record NCT02414841, source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)
- Completion: 2019-05-01 (actual) (ClinicalTrials.gov record NCT02414841, source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)
- Results first posted: 2019-08-13 (ClinicalTrials.gov record NCT02414841, source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02414841, source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02414841-2019-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
- Condition: Chronic Kidney Disease
- Intervention (Drug): Vonapanitase
- Intervention (Drug): Placebo
- Lead sponsor: Proteon Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Proteon Therapeutics (`cardio:org-proteon-therapeutics`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: PATENCY-2 trial of vonapanitase to promote radiocephalic fistula use for hemodialysis and secondary patency (`cardio:pubmed-33482699`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ebc89396b72641fe2b98efcc6b3cebea6113ff02827bd6471c8c05eaabec48cd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
